Risk of pneumonitis with different immune checkpoint inhibitors in NSCLC

Affiliations

¹ Department of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt.
² Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Editorial

Kyrillus S Shohdy et al. Ann Transl Med. 2017 Sep.

. 2017 Sep;5(17):365.

doi: 10.21037/atm.2017.06.67.

¹ Department of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt.
² Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials.
Khunger M, Rakshit S, Pasupuleti V, Hernandez AV, Mazzone P, Stevenson J, Pennell NA, Velcheti V. Khunger M, et al. Chest. 2017 Aug;152(2):271-281. doi: 10.1016/j.chest.2017.04.177. Epub 2017 May 10. Chest. 2017. PMID: 28499515

1. Naidoo J, Wang X, Woo KM, et al. Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy. J Clin Oncol 2017;35:709-17. 10.1200/JCO.2016.68.2005 - DOI - PMC - PubMed
1. Hallowell RW, Horton MR. Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced. Drugs 2014;74:443-50. 10.1007/s40265-014-0190-z - DOI - PubMed
1. Possick JD. Pulmonary Toxicities from Checkpoint Immunotherapy for Malignancy. Clin Chest Med 2017;38:223-32. 10.1016/j.ccm.2016.12.012 - DOI - PubMed
1. Khunger M, Rakshit S, Pasupuleti V, et al. Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials. Chest 2017;152:271-81. 10.1016/j.chest.2017.04.177 - DOI - PubMed
1. Abdel-Rahman O, Fouad M. Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Ther Adv Respir Dis 2016;10:183-93. 10.1177/1753465816636557 - DOI - PMC - PubMed